The 8th Yunling Breast Cancer Summit Forum | Dr. Qianjun Chen: Focusing on Controversies in HER2-Positive Breast Cancer, Multidisciplinary Collaboration Holds Great Promise

The 8th Yunling Breast Cancer Summit Forum | Dr. Qianjun Chen: Focusing on Controversies in HER2-Positive Breast Cancer, Multidisciplinary Collaboration Holds Great Promise

2025.02.13
On July 14, to mark the 40th anniversary of Yunnan Cancer Hospital, the "8th Yunling Breast Cancer Summit Forum," hosted by the Yunnan Anti-Cancer Association and the Chinese Medical Education Association, was held in Kunming. The event gathered cutting-edge advances in breast cancer from domestic and international experts. Dr. Qianjun Chen from Guangdong Provincial Hospital of Traditional Chinese Medicine delivered a keynote report on "Consensus and Controversies in Anti-HER2 Therapy for HER2-Positive Breast Cancer." "Oncology Frontier" interviewed Professor Chen on site to share insights on the consensus and controversies in anti-HER2 therapy for HER2-positive breast cancer, guiding multidisciplinary collaboration to optimize patient management strategies, extend patient survival, and improve quality of life.
Blood Science Update: Gut Microbiota in Benign and Malignant Hematopoiesis

Blood Science Update: Gut Microbiota in Benign and Malignant Hematopoiesis

2025.02.13
This article, published in the esteemed journal Blood Science, highlights the intricate role of gut microbiota in hematopoiesis, encompassing its influence on both benign and malignant conditions. As a peer-reviewed platform at the forefront of clinical and experimental hematology, Blood Science is recognized for its impact on advancing our understanding of molecular biology, physiology, and clinical applications. Authored by Professor Tao Cheng from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Med-ical College, Professor Hui Cheng from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Med-ical College and Professor Pengxu Qian from the First Affiliated Hospital, Zhejiang University School of Medicine，this work provides crucial insights into the therapeutic implications of gut microbiota for hematological health and disease management.
Blood Science Update: Epigenetic Modifications in Hematopoietic Ecosystem: A Key Tuner from Homeostasis to Acute Myeloid Leukemia

Blood Science Update: Epigenetic Modifications in Hematopoietic Ecosystem: A Key Tuner from Homeostasis to Acute Myeloid Leukemia

2025.02.13
Blood Science, an authoritative journal in the fields of hematology and oncology, has been at the forefront of advancing knowledge in blood-related disorders. Dedicated to publishing pioneering research, the journal provides a platform for understanding the complexities of blood ecosystems, from cellular mechanisms to clinical implications. By fostering collaboration and disseminating groundbreaking studies, Blood Science has shaped the way researchers and clinicians approach hematological health and disease.
Blood Science Update: The Dual Role of BCL11B in T-Cell Malignancies

Blood Science Update: The Dual Role of BCL11B in T-Cell Malignancies

2025.02.13
Blood Science continues to lead the way in elucidating  complex biological processes and their implications in disease. In this insightful review article, “Dual role of BCL11B in T-cell malignancies,” Grzegorz K. Przybylski, Julia Przybylska, and Yangqiu Li explore the paradoxical functions of the B-cell CLL/lymphoma 11B (BCL11B) gene in T-cell development and malignancies.